Aristotle Atlantic Partners, LLC Abbott Laboratories Transaction History

Aristotle Atlantic Partners, LLC

  • $3.19 Billion
  • Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 19,050 shares of ABT stock, worth $2.44 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
19,050
Previous 19,050 -0.0%
Holding current value
$2.44 Million
Previous $1.98 Million 9.7%
% of portfolio
0.07%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$100.73 - $112.44 $18 Million - $20.1 Million
-178,832 Reduced 90.37%
19,050 $1.98 Million
Q1 2024

May 15, 2024
SELL
$109.52 - $120.96 $1.34 Million - $1.48 Million
-12,202 Reduced 5.81%
197,882 $22.5 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $3.1 Million - $3.8 Million
-34,423 Reduced 14.08%
210,084 $23.1 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $525,510 - $630,524
-5,501 Reduced 2.2%
244,507 $23.7 Million
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $5.07 Million - $5.65 Million
50,278 Added 25.17%
250,008 $27.3 Million
Q1 2023

May 15, 2023
BUY
$96.86 - $114.01 $3.38 Million - $3.98 Million
34,945 Added 21.21%
199,730 $20.2 Million
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $367,311 - $430,913
3,864 Added 2.4%
164,785 $18.1 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $5.49 Million - $6.36 Million
56,736 Added 54.46%
160,921 $15.6 Million
Q2 2022

Aug 15, 2022
BUY
$102.07 - $123.37 $1.91 Million - $2.31 Million
18,691 Added 21.86%
104,185 $11.3 Million
Q1 2022

May 16, 2022
BUY
$114.02 - $139.04 $370,336 - $451,601
3,248 Added 3.95%
85,494 $10.1 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $3.51 Million - $4.3 Million
30,362 Added 58.52%
82,246 $11.6 Million
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $236,703 - $261,862
2,029 Added 4.07%
51,884 $6.13 Million
Q2 2021

Aug 16, 2021
BUY
$105.79 - $124.53 $303,511 - $357,276
2,869 Added 6.11%
49,855 $5.78 Million
Q1 2021

May 17, 2021
BUY
$108.84 - $128.23 $581,749 - $685,389
5,345 Added 12.84%
46,986 $5.63 Million
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $117,495 - $128,035
-1,119 Reduced 2.62%
41,641 $4.56 Million
Q3 2020

Nov 16, 2020
BUY
$91.64 - $111.29 $249,902 - $303,487
2,727 Added 6.81%
42,760 $4.65 Million
Q2 2020

Aug 14, 2020
BUY
$76.57 - $98.0 $302,604 - $387,296
3,952 Added 10.95%
40,033 $3.66 Million
Q1 2020

May 14, 2020
BUY
$62.82 - $91.86 $199,327 - $291,471
3,173 Added 9.64%
36,081 $2.85 Million
Q4 2019

Feb 13, 2020
BUY
$78.51 - $87.4 $305,560 - $340,160
3,892 Added 13.41%
32,908 $2.86 Million
Q3 2019

Nov 14, 2019
BUY
$81.84 - $88.74 $217,858 - $236,225
2,662 Added 10.1%
29,016 $2.43 Million
Q2 2019

Aug 13, 2019
BUY
$72.88 - $85.0 $212,736 - $248,115
2,919 Added 12.46%
26,354 $2.22 Million
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $28,209 - $34,105
-426 Reduced 1.79%
23,435 $1.87 Million
Q4 2018

Feb 13, 2019
BUY
$65.56 - $74.27 $367,136 - $415,912
5,600 Added 30.67%
23,861 $1.73 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $84,100 - $101,456
1,383 Added 8.19%
18,261 $8,000
Q2 2018

Aug 14, 2018
BUY
$57.57 - $63.54 $690,782 - $762,416
11,999 Added 245.93%
16,878 $1.03 Million
Q1 2018

Sep 10, 2018
BUY
$56.27 - $63.62 $4,332 - $4,898
77 Added 1.6%
4,879 $292,000
Q1 2018

May 14, 2018
BUY
$56.27 - $63.62 $270,208 - $305,503
4,802 New
4,802 $288,000

Others Institutions Holding ABT

# of Institutions
3,224
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Aristotle Atlantic Partners, LLC Portfolio

Follow Aristotle Atlantic Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email